Purchases and Sales Made in Q3 2023 in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during Q3 2023. The information is specifically focused on institutions that hold shares of Viridian Therapeutics, Inc.\DE.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-126K- 48.92% |
$1.91M - $3.11M
|
132K
$2.24M
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-140K- 70.14% |
$2.12M - $3.46M
|
59.6K
$1.02M
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-149K- 5.72% |
$2.25M - $3.67M
|
2.45M
$41.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-178K- 84.93% |
$2.7M - $4.41M
|
31.6K
$539K
|
|
|
Nov 14, 2023
Q3 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-223K- 52.27% |
$3.38M - $5.5M
|
203K
$3.46M
|
|
|
Nov 14, 2023
Q3 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-765K- 43.08% |
$11.6M - $18.9M
|
1.01M
$17.2M
|